Abstract
Danon disease is an X-linked lysosomal disorder, characterized by hypertrophic cardiomyopathy, skeletal myopathy and mental retardation. We report a family with a novel mutation, in which the mother and her three sons were affected with various clinical presentations. A massive hypertrophy of the left ventricle was the predominant feature in the three male patients, with different degrees of severity of cardiac symptoms, from isolated palpitations to cardiac failure and sudden death. Muscle pain and weakness were also variable, but constantly associated with increased plasma CK levels. Finally, the male patients had variable degree of a mental retardation. The mother had an attenuated phenotype, limited to a mild hypertrophic cardiomyopathy with premature ventricular contractions diagnosed during her 40’s. Microscopy examination of skeletal muscle biopsy, performed in the youngest patient, demonstrated atrophic myofibers with intracytoplasmic vacuoles suggesting lysosomal glycogen storage disease. Immunohistochemistry analyses in muscle specimen showed no detectable Lysosomal-Associated Membrane Protein-2 (LAMP-2), in keeping with the diagnosis of Danon disease. However, a very low expression of a shortened LAMP-2 protein could be evidenced by Western-blot in the patient’s fibroblasts. Molecular investigations identified a novel splicing mutation (IVS6 + 1delG) in the LAMP-2 gene. This case report highlights the intrafamilial variability of Danon disease phenotype. In this case, morphological examination of muscle biopsy, showing lysosomal storage myopathy, and immunohistochemistry analyses can provide key elements for orienting etiologic investigations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- BNP:
-
B-type natriuretic peptide
- CK:
-
Creatine kinase
- HES:
-
Hematoxylin and eosin staining
- LAMP:
-
Lysosomal-associated membrane protein
- PAS:
-
Periodic acid schiff staining
References
Arad M, Maron BJ, Gorham JM et al. (2005) Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 352:362–372
Balmer C, Ballhausen D, Bosshard NU et al. (2005) Familial X-linked cardiomyopathy (Danon disease): diagnostic confirmation by mutation analysis of the LAMP2gene. Eur J Pediatr 164:509–514
Bertini E, Donati MA, Broda P et al. (2005) Phenotypic heterogeneity in two unrelated Danon patients associated with the same LAMP-2 gene mutation. Neuropediatrics 36:309–313
Burusnukul P, de Los Reyes EC, Yinger J, Boue DR (2008) Danon disease: an unusual presentation of autism. Pediatr Neurol 39:52–54
Danon MJ, Oh SJ, DiMauro S et al. (1981) Lysosomal glycogen storage disease with normal acid maltase. Neurology 31:51–57
Eskelinen EL (2006) Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol Aspects Med 27:495–502
Fanin M, Nascimbeni AC, Fulizio L, Spinazzi M, Melacini P, Angelini C (2006) Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease. Am J Pathol 168:1309–1320
Malicdan MC, Noguchi S, Nonaka I, Saftig P, Nishino I (2008) Lysosomal myopathies: an excessive build-up in autophagosomes is too much to handle. Neuromuscul Disord 18:521–529
Maron BJ, Roberts WC, Arad M et al. (2009) Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. Jama 301:1253–1259
Murakami N, Goto Y, Itoh M et al. (1995) Sarcolemmal indentation in cardiomyopathy with mental retardation and vacuolar myopathy. Neuromuscul Disord 5:149–155
Musumeci O, Rodolico C, Nishino I et al. (2005) Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene. Neuromuscul Disord 15:409–411
Nishino I (2006) Autophagic vacuolar myopathy. Semin Pediatr Neurol 13:90–95
Nishino I, Fu J, Tanji K et al. (2000) Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 406:906–910
Prall FR, Drack A, Taylor M et al. (2006) Ophthalmic manifestations of Danon disease. Ophthalmology 113:1010–1013
Sabourdy F, Michelakakis H, Anastasakis A et al. (2009) Danon disease: further clinical and molecular heterogeneity. Muscle Nerve 39:837–844
Saftig P, Tanaka Y, Lullmann-Rauch R, von Figura K (2001) Disease model: LAMP-2 enlightens Danon disease. Trends Mol Med 7:37–39
Sugie K, Yamamoto A, Murayama K et al. (2002) Clinicopathological features of genetically confirmed Danon disease. Neurology 58:1773–1778
Sugie K, Noguchi S, Kozuka Y et al. (2005) Autophagic vacuoles with sarcolemmal features delineate Danon disease and related myopathies. J Neuropathol Exp Neurol 64:513–522
Taylor MR, Ku L, Slavov D et al. (2007) Danon disease presenting with dilated cardiomyopathy and a complex phenotype. J Hum Genet 52:830–835
Yang Z, McMahon CJ, Smith LR et al. (2005) Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children. Circulation 112:1612–1617
Acknowledgements
The authors thank M.A. Berges and M. Nieto for technical assistance. Part of this work was presented (poster) at the International Congress of Inborn Errors of Metabolism held in San Diego, CA, USA, 29 August through 02 September, 2009.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Gregory Pastores
Competing interest:
None declared.
References to electronic databases: MIM#300257, Danon disease
Rights and permissions
About this article
Cite this article
Cottinet, SL., Bergemer-Fouquet, AM., Toutain, A. et al. Danon disease: intrafamilial phenotypic variability related to a novel LAMP-2 mutation. J Inherit Metab Dis 34, 515–522 (2011). https://doi.org/10.1007/s10545-010-9251-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-010-9251-y